Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accumulated Expenses (2016 - 2025)

Biomerica's Accumulated Expenses history spans 15 years, with the latest figure at $545000.0 for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 9.32% year-over-year to $545000.0; the TTM value through Nov 2025 reached $545000.0, down 9.32%, while the annual FY2025 figure was $655000.0, 0.0% changed from the prior year.
  • Accumulated Expenses for Q4 2025 was $545000.0 at Biomerica, down from $591000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $702000.0 in Q1 2024 and bottomed at $236000.0 in Q2 2022.
  • The 5-year median for Accumulated Expenses is $606500.0 (2024), against an average of $577787.4.
  • The largest annual shift saw Accumulated Expenses plummeted 39.32% in 2022 before it surged 194.92% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $674327.0 in 2021, then grew by 3.39% to $697179.0 in 2022, then decreased by 4.19% to $668000.0 in 2023, then fell by 10.03% to $601000.0 in 2024, then fell by 9.32% to $545000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Accumulated Expenses are $545000.0 (Q4 2025), $591000.0 (Q3 2025), and $655000.0 (Q2 2025).